Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharma's Big Defeat: US Rebate Proposal Hits The End Of The Road

Executive Summary

White House will not move forward with a rebate proposal the drug industry supported as a way to lower patient drug spending.

Advertisement

Related Content

A Short Eulogy For The Rebate Rule
Drug Importation Working Group Has Been Publicly Invisible As Buzz Grows On Proposal
For All The Palace Intrigue, Rebate Rule, IPI Go To OMB For Review
One More Score: CBO Projects HHS Rebate Proposal Would Boost Part D Spending $170bn
Big Pharma Defuses Drug Pricing Landmines On Capitol Hill
Medicare's Foreign Price Bench-marking Will Only Hurt Bad Negotiators, HHS's Azar Argues

Topics

Advertisement
UsernamePublicRestriction

Register

PS125622

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel